Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response
© Nagelkerke et al.; licensee BioMed Central Ltd. 2013
Received: 16 October 2012
Accepted: 31 December 2012
Published: 7 January 2013
The hypoxia-inducible factor (HIF)-1 pathway can stimulate tumor cell migration and metastasis. Furthermore, hypoxic tumors are associated with a poor prognosis. Besides the HIF-1 pathway, the unfolded protein response (UPR) is also induced by hypoxic conditions. The PKR-like ER kinase (PERK)/activating transcription factor 4 (ATF4)-arm of the UPR induces expression of lysosomal-associated membrane protein 3 (LAMP3), a factor that has been linked to metastasis and poor prognosis in solid tumors. In this study the role of UPR-induced LAMP3 in hypoxia-mediated migration of breast cancer cells was examined.
A number of in vitro metastasis models were used to study the migration and invasion of MDA-MB-231 breast cancer cells under hypoxic conditions. PERK, ATF4 and their downstream factor LAMP3 were knocked down to examine their role in cell migration. In addition, multicellular tumor spheroids were used to study the involvement of the tumor microenvironment in invasion.
Using transwell assays, migration of different breast cancer cell lines was assessed. A direct correlation was found between cell migration and baseline LAMP3 expression. Furthermore, moderate hypoxia (1% O2) was found to be optimal in stimulating migration of MDA-MB-231 cells. siRNA mediated knockdown of PERK, ATF4 and LAMP3 reduced migration of cells under these conditions. Using gap closure assays, similar results were found. In a three-dimensional invasion assay into collagen, LAMP3 knockdown cells showed a diminished capacity to invade compared to control cells when collectively grown in multicellular spheroids.
Thus, the PERK/ATF4/LAMP3-arm of the UPR is an additional pathway mediating hypoxia-induced breast cancer cell migration.
Breast cancer mortality is caused foremost by the spread of cancer cells within the host in a process called metastasis . Before tumor cells can metastasize, the tumor will need to invade, seek access to the lymphatic or vascular system and colonize the metastatic site [2, 3]. Insights in this process will aid in the prevention of cancer metastasis and help improve prognosis.
An important characteristic of most solid tumors is the presence of hypoxic regions [4–6]. Absent or inadequate vasculature within the tumor causes disruption of the supply of blood and consequentially an impaired delivery of oxygen and nutrients and an impaired removal of carbon dioxide and waste products. Several studies found low oxygen tension in tumors to be an adverse prognostic marker in different tumor types [7–10]. In addition, endogenous hypoxia-related markers, such as carbonic anhydrase-IX, were also shown to negatively influence patient outcome in breast cancer [11, 12]. Furthermore, hypoxic tumors were found to correlate with metastatic occurrences: patients with hypoxic primary tumors developed more metastases than patients with less hypoxic tumors [7, 13–15]. Mechanistically, numerous factors have been identified that are induced by hypoxia and that can promote metastasis (reviewed in [16–20]). The common denominator of most, if not all, of these factors is that they are either directly or indirectly influenced by the action of the family of master transcription regulators during hypoxic conditions: the hypoxia-inducible factor (HIF)-family .
Recently, a separate pathway from the HIFs was described, which is able to regulate gene expression during hypoxia, namely the unfolded protein response or UPR [21–24]. Within this response three distinct arms have been classified: the PKR-like endoplasmic reticulum kinase (PERK)/activating transcription factor 4 (ATF4)-arm, the inositol-requiring protein 1 (IRE1)-arm and the activating transcription factor 6 (ATF6)-arm. These pathways are activated during endoplasmic reticulum stress conditions and enable cell survival by regulating apoptosis, angiogenesis and autophagy [22–25]. Thus far, the UPR has not been directly implicated in hypoxia-induced metastasis. However, recently lysosomal-associated membrane protein 3 (LAMP3, also known as DC-LAMP, TSC-403 or CD208) was identified as a factor induced by hypoxia as part of the PERK/ATF4 arm of the UPR [26, 27]. In addition, we found that LAMP3 has prognostic relevance in breast cancer . Two homologs of LAMP3, LAMP1 and LAMP2, have been associated with cancer metastasis previously [29, 30]. LAMP3 itself was also found to be involved in metastasis: overexpression of LAMP3 in a cervical xenograft model showed an increased metastatic potential . In what way LAMP3 is involved in breast cancer metastasis and which role hypoxia may have in this process is unknown. Therefore, we set out to determine whether the UPR can influence migration and invasion of breast cancer cells via LAMP3 under hypoxic conditions.
Materials and methods
Cell culture and hypoxic incubations
All cell lines used were obtained from LGC Promochem (Teddington, UK) and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (vol/vol) fetal bovine serum (FBS), 20 mM Hepes, 1 × nonessential amino acid, 2 mM L-glutamine and 10 U/ml penicillin, 10 μg/ml streptomycin (all from PAA Laboratories, Cölbe, Germany) at 37°C with 5% CO2. Hypoxic conditions were induced with a H35 Hypoxystation (Don Whitley Scientific Ltd, Shipley, UK).
Cell migration using modified Boyden Chambers
Membranes with 8 μm pores (Greiner Bio-one, Alphen a/d Rijn, The Netherlands) were used in a 24-wells format. A total of 40,000 cells, serum-starved overnight where indicated, were added to the upper compartment. The lower compartment was filled with standard cell culture medium. Cells were allowed to migrate for 24 hours, after which chambers were fixed for 10 minutes in cold 70% ethanol. Membranes were stained with 0.5% (w/v) crystal violet (Sigma-Aldrich, St. Louis, MO, USA) for 30 minutes and subsequently washed thoroughly with tap water. Cells that had not migrated to the lower compartment were removed with a cotton swab. Migrated cells were quantified by solubilizing bound crystal violet in 1% (wt/vol) sodium dodecyl sulfate (SDS, Sigma-Aldrich) for 1 hour at 37°C. Absorbance was measured at 595 nm.
RNA isolation, cDNA synthesis and quantitative polymerase chain reactions (qPCR)
RNA was isolated with Norgen's total RNA purification kit (Norgen Biotek Corp., Thorold, Canada) and stored at -80°C until further processing. cDNA was synthesized using the iScript cDNA synthesis kit (Bio-Rad Laboratories Inc., Richmond, CA, USA) with 1 μg RNA as input. The following primers were used for the qPCR: PERK FW: 5'-CTGATTTTGAGCCAATTC-3' and RV: 5'- CCGGTACTCGCGTCGCTG-3', ATF4 FW: 5'-CCTTCACCTTCTTACAACCT-3' and RV: 5'-GTAGTCTGGCTTCCTATCTC-3', LAMP3 FW: 5'-TGAAAACAACCGATGTCCAA-3' and RV: 5'-TCAGACGAGCACTCATCCAC-3'.
qPCR was carried out on a CFX96 real-time PCR detection system (Bio-Rad) with SYBR Green (Applied Biosystems, Foster City, CA, USA). As a reference gene, hypoxanthine-guanine phosphoribosyltransferase (HPRT) in a pre-developed assay (Applied Biosystems) was used.
Cells were transfected transiently for PERK, ATF4 or LAMP3 using mission siRNAs (Sigma-Aldrich):
PERK (NM_004836), SASI_Hs01_00096845 and SASI_Hs01_00096846
ATF4 (NM_001675), SASI_Hs02_00332313 and SASI_Hs01_00175197
LAMP3 (NM_014398), SASI_Hs01_00214233 and SASI_Hs02_00345584
Transfections were performed using Saint-Red (Synvolux Therapeutics, Groningen, The Netherlands) according to the manufacturer's instructions.
Generation of stable MDA-MB-231 shLamp3 pools
A U6 promoter-driven short hairpin RNA (shRNA) expression vector targeting LAMP3 and a non-targeting control vector (PLKO1_shLAMP3 (TRCN0000148784, number 842) and PLKO.1 control, respectively) were purchased from Sigma-Aldrich. Briefly, pseudotyped lentiviral particles were produced in HEK293FT cells using the ViraPower lentiviral expression system according to the manufacturer's instructions (Invitrogen, Carlsbad, CA, USA). MDA-MB-231 cells were infected at a low passage number after which a pool of transfected cells was derived by puromycin (4 μg/ml) selection for approximately 10 days.
For the colony-forming assays 500 transiently transfected cells were plated in T25 cell culture flasks (Greiner Bio-one) and allowed to adhere overnight. Cells were incubated under hypoxic conditions (1% O2) for 24 hours after which they were transferred to the normoxic incubator and given time to form colonies. Once colonies in the normoxic controls comprised of at least 50 cells, flasks were fixated in 70% ethanol for 10 minutes at 4°C and stained with 0.5% crystal violet for 30 minutes. Colonies of at least 50 cells were scored manually.
Gap closure assays
Monolayer gap closure assays (formerly known as scratch assays) were conducted using silicone cell culture inserts (Ibidi, Martinsried, Germany) attached to culture plates. In short, 30,000 cells were seeded in the inserts and allowed to recover overnight to form a confluent monolayer. Inserts were removed with tweezers, after which cells were rinsed thrice with Hank's buffered saline solution (HBSS, PAA Laboratories) to remove detached cells. Culture medium was re-added and closure of the gap was followed for 24 hours using live imaging (see below). Gap closure was quantified using ImageJ (National Institutes of Health, Bethesda, MD, USA).
Multicellular tumor spheroids were prepared from conventional monolayer cultures using an adapted liquid overlay technique. In short, V-shaped 96-wells plates (Greiner Bio-one) were coated with 0.5% (wt/vol) poly-HEMA (Sigma-Aldrich). A total of 1,000 cells in 100 μl of standard culture medium with 2.5% (vol/vol) Matrigel (BD Biosciences, San Jose, CA, USA) were added to each well, after which cells were spun down for 10 minutes at 1,000 × g. Within 24 hours spheroids were formed.
After formation, MDA-MB-231 spheroids were incubated for 1 hour with 200 μM of pimonidazole (1-[(2-hydroxy-3-piperidinyl)propyl]-2-nitroimidazole hydrochloride, Natural Pharmacia International Inc., Burlington, MA, USA). Next, spheroids were fixed in 4% paraformaldehyde (Merck Chemicals, Darmstadt, Germany), and embedded in paraffin. Staining was performed on 5-μm sections as previously described , using the following antibodies: mouse-anti-pimonidazole (Natural Pharmacia International Inc.) diluted 1:800 and biotin-conjugated donkey anti-mouse IgG (715-066-150, Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA) diluted 1:200.
Cell labeling with cell tracker
To label cells with CellTracker Green (Life Technologies, Carlsbad, CA, USA) or CellTracker Orange (Life Technologies), 0.15 × 106 cells/ml were seeded in a T75 cell culture flask (Greiner Bio-one). Cells were allowed to adhere, after which CellTracker was dissolved in DMSO and added at 10 μM to the cell culture medium. Flasks were incubated at 37°C for 45 minutes. Next, cell culture medium was replenished and cells were allowed to recover for 30 minutes, after which they were ready for further experimentation.
Spheroid invasion assays in collagen
Twenty-four hours after formation, spheroids were embedded into collagen. Spheroids were collected in a 15 ml tube and allowed to descend to the bottom. Cell culture medium was renewed once. Next, the spheroids were combined with 4 mg/ml of rat-tail collagen type I (BD Biosciences), according to the manufacturer's instructions. The collagen was allowed to polymerize for 10 minutes at room temperature, after which the mixture was pipetted carefully into a 12-wells plate (Greiner Bio-one). The collagen disk was incubated at 37°C until fully solidified, after which standard cell culture medium was added. Spheroids were allowed to invade the collagen for several days, as indicated in the legends to the figures.
After invasion of spheroids into collagen, collagen disks were fixed in 4% paraformaldehyde for 30 minutes at room temperature. Next, disks were washed with PBS, after which they were incubated with Alexa 488-conjugated Phalloidin (1:100; Life Technologies) for 3 hours at room temperature. After washing once more with PBS, images were acquired.
Live imaging and microscopy
Live imaging of cells was performed using the JULI (Just Unbelievable Live Imaging) system from PAA. All other microscopic images were obtained using a Leica DM 6000 fluorescence microscope in combination with IPLab imaging software (Scanalytics Inc., Fairfax, VA, USA).
Data analysis and statistics
Unless stated otherwise, all data are presented as mean values ± standard deviation. Statistical analysis was carried out using Student's t tests or one-way analysis of variance (ANOVA) with Tukey's post hoc test where appropriate unless stated otherwise. Two-sided P values < 0.05 were considered statistically significant. Asterisks indicate statistical significance: *** is P < 0.001, ** is P < 0.01 and * is P < 0.05.
Breast cancer cell migration in transwell assays
Importance of serum deprivation on migration of MDA-MB-231 cells in a transwell assay
Effect of knockdown of PERK, ATF4 and LAMP3 on cell migration in transwell assay during hypoxia
Migration of MDA-MB-231 breast cancer cells in a gap closure assay under hypoxic conditions
Effect of knockdown of PERK, ATF4 and LAMP3 on cell migration during hypoxia in a gap closure assay
Importance of the tumor microenvironment for migration of MDA-MB-231 cells
Effect of LAMP3 knockdown on collagen invasion of MDA-MB-231 spheroids
The diminished invasion of LAMP3 knockdown spheroids was validated further by generating spheroids of a mixed origin. Control cells were labeled with CellTracker Green and LAMP3 knockdown cells were labeled with CellTracker Orange. Subsequently, mixed spheroids in a 1:1 ratio were generated. Invasion of these spheroids in collagen demonstrated the enhanced ability of the control cells to deeply invade the collagen compared to the LAMP3 knockdown cells (see Figure 7E). This effect was quantified by analyzing the green and red signal present within the spheroid body and the invasive zone (see Figure 7F). The invasive zone was divided into four circular zones with increasing distance from the spheroid body. Analysis of the signal present within each zone revealed that the green signal was more prevalent in the invasive zones than the red signal, indicating that the control cells invaded the collagen deeper than the LAMP3 knockdown cells.
In this study, evidence is provided that UPR-induced LAMP3 can influence hypoxia-mediated cell migration of breast cancer cells. We provide evidence that apart from the established involvement of the HIF-pathway in the induction of cancer cell spread, the UPR is a second manner in which hypoxia is implicated in breast cancer cell migration.
A characteristic of the UPR is its maximum induction under conditions of severe hypoxia (< 0.2% O2) or anoxia . Indeed, LAMP3 as a UPR-induced factor was found to have its peak of induction under these conditions [26, 28]. However, cell migration and invasion is often studied under conditions of more moderate hypoxia, around 1% oxygen [33–38], conditions which maximally induce HIF-1α expression . The current study shows that knockdown of PERK, ATF4 or LAMP3 in combination with hypoxic exposure to 1% O2 led to a reduction in cell migration. If the UPR and its associated factors are maximally induced by anoxia, why are the largest effects observed at moderate levels of hypoxia? Several studies have shown that the UPR can indeed be induced by moderate hypoxia as well, but with different kinetics [21, 39, 40]. In this study assays were performed at 1% O2 as stronger hypoxic conditions did not lead to a stimulation of cell migration. Possibly, at severe hypoxic conditions, cells apply the UPR more for cell survival  than migration.
In the transwell assays an intriguing effect of the addition of serum on the induction of cell migration by hypoxia was observed. Serum-starved cells migrated most profoundly at 1% O2, whereas serum-supplemented cells migrated best at 0.1% O2. Serum dependency of cancer cell invasion has been observed before [41, 42]. When MDA-MB-231 cells were serum depleted, no increase in invasion was found for a hypoxic incubation (1.5% O2) . As addition of serum led to an increased invasion under hypoxia, it was suggested that serum might contain factors that increase invasion under hypoxic conditions . In a different study, the effect of hepatocyte growth factor (HGF) on tumor invasion was examined in U2-OS and SiHa cells . Mild hypoxia (3% O2) was found to increase invasion by amplifying HGF signaling, thereby sensitizing cells to HGF stimulation . These and the current data indicate that the role of serum in cancer cell migration and invasion is more than just a chemoattractant and that growth factor signaling has a vast influence on the effects of hypoxia in migration and invasion assays. Trying to survive during hypoxia is of critical importance for cells. Depriving cells of serum may make survival even more difficult. Possibly, without serum and under severe hypoxic conditions (0.1% O2) cells are not migrating as fast as under moderate hypoxia (1% O2) because cell survival is more essential. When serum is present, the need for survival may become less critical even at 0.1% O2, causing the increase in cell migration.
The importance of the tumor microenvironment during cell migration was emphasized when migration assays were performed with cells grown as monolayer and cells initially grown as spheroids. The latter were found to be more migratory than the former. In other words, cells that experienced a simplified microenvironment prior to the assay were more migratory, despite the fact that spheroids had to be disintegrated back to a single-cell suspension. This behavior was also observed previously with murine breast cancer cell lines in transwell invasion assays . As the spheroids used contain a central hypoxic core, the enhanced ability of spheroid cells to migrate or invade could be a consequence of hypoxia. This, however, remains to be established.
With the evidence that LAMP3 is involved in hypoxia-induced cell migration, it needs to be elucidated which mechanism LAMP3 uses to cause the actual spread of cancer cells. LAMP3 protein under physiological conditions is localized within the lysosomal membrane . For LAMP1 and LAMP2 it has been previously established that their expression can relocalize to the plasma membrane in cancer cells . Cell lines with a stronger metastatic capacity showed an enhanced expression of LAMP1 and LAMP2 on the cell membrane . It is believed that LAMP surface expression provides a cancer cell with means to attach to selectins on endothelial cells and enhance their capacity to form metastases . A similar mechanism could be responsible for the role of LAMP3 in hypoxia-induced cell migration. LAMP3 was found to have the ability to relocalize to the plasma membrane upon influenza A virus infections in HeLa cells . Nevertheless, we have not been able to show LAMP3 expression on the cell surface in the MDA-MB-231 cells used, under either normoxic or hypoxic conditions. Immunohistochemically, in MDA-MB-231 cells we have only observed LAMP3 expression in the cytoplasm. An alternative explanation for the function of LAMP3 in cell migration is the link LAMP proteins have with autophagy . Autophagy has been previously suggested as a possible mechanism responsible for increased survival and increased metastasis of cancer cells [48, 49]. Analysis of the autophagy marker LC3B expression in a large subset of breast tumors revealed that it is associated with metastasis and a worse outcome . However, Indelicato et al. found that chemically induced autophagy results in reduced invasion of MDA-MB-231 cells under both normoxic and hypoxic (1% O2) conditions, whereas LC3B silenced cells showed a decreased invasion during hypoxic conditions . Thus, there is evidence that autophagy may function as a mechanism behind hypoxia-induced metastasis, but its precise role is far from clarified.
In conclusion, this study provides evidence that the UPR with LAMP3 is involved in the process of hypoxia-induced cell migration. In addition, growth factor signaling via the serum component of cell culture medium is a factor of vital importance in the migration of cells under conditions of both moderate and severe hypoxia. Furthermore, the tumor microenvironment, experienced by cells when grown as multicellular spheroids is of significance in the process of cell migration and invasion. The PERK/ATF4/LAMP3 arm of the UPR might function as a new target for therapy combating hypoxia-induced metastasis in breast cancer.
activating transcription factor 4
activating transcription factor 6
Dulbecco's modified Eagle's medium
fetal bovine serum
Hank's buffered saline solution
hepatocyte growth factor
inositol-requiring protein 1
lysosomal-associated membrane protein 3
phosphate-buffered saline pH 7.4
PKR-like endoplasmic reticulum kinase
quantitative polymerase chain reaction
short hairpin RNA
small interfering RNA
unfolded protein response.
Maurits en Anna de Kock Stichting.
- Weigelt B, Peterse JL, van 't Veer LJ: Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005, 5: 591-602.View ArticlePubMedGoogle Scholar
- Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144: 646-674. 10.1016/j.cell.2011.02.013.View ArticlePubMedGoogle Scholar
- Friedl P, Locker J, Sahai E, Segall JE: Classifying collective cancer cell invasion. Nat Cell Biol. 2012, 14: 777-783. 10.1038/ncb2548.View ArticlePubMedGoogle Scholar
- Brown JM: Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol. 1979, 52: 650-656. 10.1259/0007-1285-52-620-650.View ArticlePubMedGoogle Scholar
- Thomlinson RH, Gray LH: The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 1955, 9: 539-549. 10.1038/bjc.1955.55.View ArticlePubMedPubMed CentralGoogle Scholar
- Rademakers SE, Span PN, Kaanders JH, Sweep FC, van der Kogel AJ, Bussink J: Molecular aspects of tumour hypoxia. Mol Oncol. 2008, 2: 41-53. 10.1016/j.molonc.2008.03.006.View ArticlePubMedGoogle Scholar
- Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW: Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997, 38: 285-289. 10.1016/S0360-3016(97)00101-6.View ArticlePubMedGoogle Scholar
- Hockel M, Schlenger K, Hockel S, Vaupel P: Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res. 1999, 59: 4525-4528.PubMedGoogle Scholar
- Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ, de Wilde PC, Bussink J, Raleigh JA, van der Kogel AJ: Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res. 2002, 62: 7066-7074.PubMedGoogle Scholar
- Bussink J, Kaanders JH, van der Kogel AJ: Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol. 2003, 67: 3-15. 10.1016/S0167-8140(03)00011-2.View ArticlePubMedGoogle Scholar
- Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL: Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol. 2001, 19: 3660-3668.PubMedGoogle Scholar
- Span PN, Bussink J, Manders P, Beex LV, Sweep CG: Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome. Br J Cancer. 2003, 89: 271-276. 10.1038/sj.bjc.6601122.View ArticlePubMedPubMed CentralGoogle Scholar
- Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996, 56: 4509-4515.PubMedGoogle Scholar
- Nordsmark M, Overgaard M, Overgaard J: Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 1996, 41: 31-39.View ArticlePubMedGoogle Scholar
- Sundfor K, Lyng H, Rofstad EK: Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer. 1998, 78: 822-827. 10.1038/bjc.1998.586.View ArticlePubMedPubMed CentralGoogle Scholar
- Chan DA, Giaccia AJ: Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev. 2007, 26: 333-339. 10.1007/s10555-007-9063-1.View ArticlePubMedGoogle Scholar
- Chaudary N, Hill RP: Hypoxia and metastasis in breast cancer. Breast Dis. 2006, 26: 55-64.View ArticlePubMedGoogle Scholar
- Gort EH, Groot AJ, van der Wall E, van Diest PJ, Vooijs MA: Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr Mol Med. 2008, 8: 60-67. 10.2174/156652408783565568.View ArticlePubMedGoogle Scholar
- Le QT, Denko NC, Giaccia AJ: Hypoxic gene expression and metastasis. Cancer Metastasis Rev. 2004, 23: 293-310.View ArticlePubMedGoogle Scholar
- Lunt SJ, Chaudary N, Hill RP: The tumor microenvironment and metastatic disease. Clin Exp Metastasis. 2009, 26: 19-34. 10.1007/s10585-008-9182-2.View ArticlePubMedGoogle Scholar
- Koumenis C, Naczki C, Koritzinsky M, Rastani S, Diehl A, Sonenberg N, Koromilas A, Wouters BG: Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol Cell Biol. 2002, 22: 7405-7416. 10.1128/MCB.22.21.7405-7416.2002.View ArticlePubMedPubMed CentralGoogle Scholar
- Feldman DE, Chauhan V, Koong AC: The unfolded protein response: a novel component of the hypoxic stress response in tumors. Mol Cancer Res. 2005, 3: 597-605. 10.1158/1541-7786.MCR-05-0221.View ArticlePubMedGoogle Scholar
- Koumenis C, Wouters BG: "Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways. Mol Cancer Res. 2006, 4: 423-436. 10.1158/1541-7786.MCR-06-0150.View ArticlePubMedGoogle Scholar
- Wouters BG, Koritzinsky M: Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer. 2008, 8: 851-864. 10.1038/nrc2501.View ArticlePubMedGoogle Scholar
- Rouschop KM, van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW, Lambin P, van der Kogel AJ, Koritzinsky M, Wouters BG: The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest. 2010, 120: 127-141. 10.1172/JCI40027.View ArticlePubMedGoogle Scholar
- Mujcic H, Rzymski T, Rouschop KM, Koritzinsky M, Milani M, Harris AL, Wouters BG: Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3. Radiother Oncol. 2009, 92: 450-459. 10.1016/j.radonc.2009.08.017.View ArticlePubMedGoogle Scholar
- Ozaki K, Nagata M, Suzuki M, Fujiwara T, Ueda K, Miyoshi Y, Takahashi E, Nakamura Y: Isolation and characterization of a novel human lung-specific gene homologous to lysosomal membrane glycoproteins 1 and 2: significantly increased expression in cancers of various tissues. Cancer Res. 1998, 58: 3499-3503.PubMedGoogle Scholar
- Nagelkerke A, Mujcic H, Bussink J, Wouters BG, van Laarhoven HW, Sweep FC, Span PN: Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer. Cancer. 2011, 117: 3670-3681. 10.1002/cncr.25938.View ArticlePubMedGoogle Scholar
- Saitoh O, Wang WC, Lotan R, Fukuda M: Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem. 1992, 267: 5700-5711.PubMedGoogle Scholar
- Sawada R, Lowe JB, Fukuda M: E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. J Biol Chem. 1993, 268: 12675-12681.PubMedGoogle Scholar
- Kanao H, Enomoto T, Kimura T, Fujita M, Nakashima R, Ueda Y, Ueno Y, Miyatake T, Yoshizaki T, Buzard GS, Tanigami A, Yoshino K, Murata Y: Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer. Cancer Res. 2005, 65: 8640-8645. 10.1158/0008-5472.CAN-04-4112.View ArticlePubMedGoogle Scholar
- Mazure NM, Pouyssegur J: Hypoxia-induced autophagy: cell death or cell survival?. Curr Opin Cell Biol. 2010, 22: 177-180. 10.1016/j.ceb.2009.11.015.View ArticlePubMedGoogle Scholar
- Canning MT, Postovit LM, Clarke SH, Graham CH: Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells. Exp Cell Res. 2001, 267: 88-94. 10.1006/excr.2001.5243.View ArticlePubMedGoogle Scholar
- Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ: Lysyl oxidase is essential for hypoxia-induced metastasis. Nature. 2006, 440: 1222-1226. 10.1038/nature04695.View ArticlePubMedGoogle Scholar
- Funasaka T, Yanagawa T, Hogan V, Raz A: Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia. FASEB J. 2005, 19: 1422-1430. 10.1096/fj.05-3699com.View ArticlePubMedGoogle Scholar
- Graham CH, Forsdike J, Fitzgerald CJ, Macdonald-Goodfellow S: Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer. 1999, 80: 617-623. 10.1002/(SICI)1097-0215(19990209)80:4<617::AID-IJC22>3.0.CO;2-C.View ArticlePubMedGoogle Scholar
- Indelicato M, Pucci B, Schito L, Reali V, Aventaggiato M, Mazzarino MC, Stivala F, Fini M, Russo MA, Tafani M: Role of hypoxia and autophagy in MDA-MB-231 invasiveness. J Cell Physiol. 2010, 223: 359-368.PubMedGoogle Scholar
- Postovit LM, Adams MA, Lash GE, Heaton JP, Graham CH: Oxygen-mediated regulation of tumor cell invasiveness. Involvement of a nitric oxide signaling pathway. J Biol Chem. 2002, 277: 35730-35737. 10.1074/jbc.M204529200.View ArticlePubMedGoogle Scholar
- Fels DR, Koumenis C: The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biol Ther. 2006, 5: 723-728.View ArticlePubMedGoogle Scholar
- Koritzinsky M, Magagnin MG, van den Beucken T, Seigneuric R, Savelkouls K, Dostie J, Pyronnet S, Kaufman RJ, Weppler SA, Voncken JW, Lambin P, Koumenis C, Sonenberg N, Wouters BG: Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J. 2006, 25: 1114-1125. 10.1038/sj.emboj.7600998.View ArticlePubMedPubMed CentralGoogle Scholar
- Reshkin SJ, Bellizzi A, Albarani V, Guerra L, Tommasino M, Paradiso A, Casavola V: Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na(+)/H(+) exchange, motility, and invasion induced by serum deprivation. J Biol Chem. 2000, 275: 5361-5369. 10.1074/jbc.275.8.5361.View ArticlePubMedGoogle Scholar
- Munoz-Najar UM, Neurath KM, Vumbaca F, Claffey KP: Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene. 2006, 25: 2379-2392. 10.1038/sj.onc.1209273.View ArticlePubMedGoogle Scholar
- Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM: Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell. 2003, 3: 347-361. 10.1016/S1535-6108(03)00085-0.View ArticlePubMedGoogle Scholar
- Krohn A, Song YH, Muehlberg F, Droll L, Beckmann C, Alt E: CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro. Cancer Lett. 2009, 280: 65-71. 10.1016/j.canlet.2009.02.005.View ArticlePubMedGoogle Scholar
- de Saint-Vis B, Vincent J, Vandenabeele S, Vanbervliet B, Pin JJ, Ait-Yahia S, Patel S, Mattei MG, Banchereau J, Zurawski S, Davoust J, Caux C, Lebecque S: A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity. 1998, 9: 325-336. 10.1016/S1074-7613(00)80615-9.View ArticlePubMedGoogle Scholar
- Zhou Z, Xue Q, Wan Y, Yang Y, Wang J, Hung T: Lysosome-associated membrane glycoprotein 3 is involved in influenza A virus replication in human lung epithelial (A549) cells. Virol J. 2011, 8: 384-10.1186/1743-422X-8-384.View ArticlePubMedPubMed CentralGoogle Scholar
- Eskelinen EL: Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med. 2006, 27: 495-502. 10.1016/j.mam.2006.08.005.View ArticlePubMedGoogle Scholar
- Macintosh RL, Timpson P, Thorburn J, Anderson KI, Thorburn A, Ryan KM: Inhibition of autophagy impairs tumor cell invasion in an organotypic model. Cell Cycle. 2012, 11: 2022-2029. 10.4161/cc.20424.View ArticlePubMedPubMed CentralGoogle Scholar
- Vigneswaran N, Wu J, Song A, Annapragada A, Zacharias W: Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC). Exp Mol Pathol. 2011, 90: 215-225. 10.1016/j.yexmp.2010.11.011.View ArticlePubMedPubMed CentralGoogle Scholar
- Lazova R, Camp RL, Klump V, Siddiqui SF, Amaravadi RK, Pawelek JM: Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin Cancer Res. 2012, 18: 370-379. 10.1158/1078-0432.CCR-11-1282.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.